Page last updated: 2024-12-07

dl 111-it

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole: non-hormonal antifertility agent; RN & N1 from CA Vol 90 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122000
CHEMBL ID18410
SCHEMBL ID3500575
MeSH IDM0495553

Synonyms (31)

Synonym
contragestazol
st-1959 ,
dl-111-it
l 14111
dl 111
1h-1,2,4-triazole, 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-
s-triazole, 3-(o-ethylphenyl)-5-(m-methoxyphenyl)-
(3-ethylphenyl)-5-(3-methoxyphenyl)-1,2,4-triazole
3-(o-ethylphenyl)-5-(m-methoxyphenyl)-s-triazole
dl-111 ,
l-14111
5-(2-ethylphenyl)-3-(3-methoxyphenyl)-1h-1,2,4-triazole
5-(2-ethylphenyl)-3-(3-methoxyphenyl)-s-triazole
3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1h-1,2,4-triazole
dl 111it
dl 111-it
dl111-it
st1959
69095-83-6
CHEMBL18410
diphenytriazol
unii-5hk8o3ma34
5hk8o3ma34 ,
SCHEMBL3500575
GXCZZAKPGMYPDJ-UHFFFAOYSA-N
3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1h-1,2,4 triazole
5-(2-ethyl-phenyl)-3-(3-methoxy-phenyl)-1h-(1,2,4) triazole
dl-111it
dl111
1h-1,2,4-triazole, 5-(2-ethylphenyl)-3-(3-methoxyphenyl)-
DTXSID20988816

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic profiles of a new non-hormonal anti-fertility agent, DL 111-IT, were studied in rats and hamsters given the 14C labelled compound parenterally dissolved in aqueous or oily vehicles."( Pharmacokinetics-activity relationships of a new non-hormonal antifertility agent: 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1, 2,4-triazole, in the rat and the hamster.
Assandri, A; Galliani, G; Omodei-Salé, A; Perazzi, A; Sartori, G, 1983
)
0.5

Compound-Compound Interactions

ExcerptReferenceRelevance
"To clarify the role of DL111-IT when combined with mifepristone (Mif) on termination of early pregnancy."( Synergistic effects on pregnancy-termination activity of DL111-IT in combination with mifepristone.
Fang, RY; Yang, B, 1996
)
0.29
"The objectives of this study were to determine the synergistic effects of DL111-IT in combination with mifepristone (RU486) on termination of early pregnancy in rhesus monkeys."( Synergistic effects of DL111-IT combined with mifepristone on termination of early pregnancy in rhesus monkeys.
Fang, RY; He, QJ; Yang, B; Ying, Y, 2000
)
0.31
"DL111-IT, a non-hormonal contragestional agent, revealed synergistic effects in combination with mifepristone (RU486) in some species."( Effects of DL111-IT or combined with RU486 on uterine polyamines biosynthesis in rats during early gestation.
Fang, R; He, Q; Shentu, J; Wang, L; Zhou, H, 2001
)
0.31
"This study evaluated the effectiveness and acute toxicity of DL111-IT combined with mifepristone (RU486) and misoprostol (MISO) on early pregnancy termination."( Synergistic effects of DL111-IT in combination with mifepristone and misoprostol on termination of early pregnancy in preclinical studies.
Fang, RY; He, QJ; Wang, WF; Wu, HH; Yang, B, 2003
)
0.32

Dosage Studied

ExcerptRelevanceReference
" Most of the members of these series of compounds are effective with a single injection although the dosage can be 5 or more times as large as that needed for each of 5 daily injections."( Development of novel embryotoxic compounds for interceptive fertility control in the dog.
Lerner, LJ, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID176615Pregnancy-terminating activity in rat when administered po1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
A new class of nonhormonal pregnancy-terminating agents. Synthesis and contragestational activity of 3,5-diaryl-s-triazoles.
AID176616Pregnancy-terminating activity in rat when administered sc1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
A new class of nonhormonal pregnancy-terminating agents. Synthesis and contragestational activity of 3,5-diaryl-s-triazoles.
AID84860Pregnancy-terminating activity in hamster when administered sc1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
A new class of nonhormonal pregnancy-terminating agents. Synthesis and contragestational activity of 3,5-diaryl-s-triazoles.
AID84858Pregnancy-terminating activity in hamster when administered perorally1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
A new class of nonhormonal pregnancy-terminating agents. Synthesis and contragestational activity of 3,5-diaryl-s-triazoles.
AID178499Compound was tested for in vitro activity of luteolysis on corpora lutea from pseudopregnant rats2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Non-steroidal pregnancy-terminating agents: design, synthesis and structure-activity relationships of 2-aryl-1,2,4-triazolo[1,5-a]pyridine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (36.11)18.7374
1990's6 (16.67)18.2507
2000's16 (44.44)29.6817
2010's1 (2.78)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.65 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]